Przemysław Radwański

Przemysław Radwański studies heart rhythm disorders (arrhythmias), including atrial fibrillation and ventricular arrhythmias, using both large-scale observational patient data and laboratory studies of the cardiac sodium channel NaV1.5 that helps control heartbeats. Much of the recent work examines whether existing drugs prescribed for other conditions (such as lamotrigine, riluzole, ivabradine, and omega-3/icosapent ethyl formulations) are linked to increased or decreased risk of arrhythmias or heart failure. This research could interest students interested in cardiac electrophysiology, pharmacoepidemiology, and computational/machine-learning approaches to ion channel function.

Publication output has grown over the last decade, rising from roughly 4-6 papers per year earlier on to 12-16 per year in 2022-2025, indicating an increasing pace of research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026